Roche’s Product Development organization, structured by therapeutic area, is accountable for the design and execution of late-stage clinical development strategies and plans aimed at delivering medically differentiated therapies that demonstrate clinically meaningful benefit to patients. Roche is seeking a Global Development Lead (GDL) to provide strategic and scientific leadership for the clinical development of a new asset and/or indications within the Cardiovascular, Renal, and Metabolism (CVRM) therapeutic area. The GDL is accountable for the development of the Clinical Development (CD) strategy, the design and execution of the CD plan, and the operational oversight of clinical programs for assigned molecule(s)/indication(s). This role requires strong cross-functional collaboration to ensure alignment across regulatory, biomarker, safety, and commercial functions. The GDL also contributes to overarching therapeutic area strategies, bringing deep clinical expertise and scientific insight to inform portfolio decisions. This is a key leadership role with the opportunity to shape the development path of an innovative CVRM therapy within Roche’s pipeline. The ideal candidate will have experience in the Cardiovascular, Renal & Metabolic space; along with extensive experience in late stage drug development and managing large-scale clinical trials.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees